Structure–Activity Relationship for Alkylating Dipeptide Nitrogen Mustard Derivatives
Keywords: Alkylating peptides; Cell lines; Cytotoxicity; J1; Melphalan; P2; Peptichemio
Document Type: Research Article
Affiliations: 1: *Department of Medical Sciences, Division of Clinical Pharmacology, Uppsala University, SE-751 85 Uppsala, Sweden 2: †Department of Chemistry, Medicinal Chemistry, Göteborg University, SE-412 96 Göteborg, Sweden 3: ‡Institute of Pharmacy, Department of Medicinal Chemistry, University of Tromsø, N-9037 Tromsø, Norway 4: §Karolinska Pharmacy, Karolinska Institutet, SE-171 76 Stockholm, Sweden 5: ¶Department of Oncology-Pathology, Karolinska Institutet, SE-171 76 Stockholm, Sweden 6: #Department of Oncology, Radiology and Clinical Immunology, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
Publication date: 01 January 2003
Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.
- Editorial Board
- Information for Authors
- Submit a Paper
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content